Danish pharmaceutical company Novo Nordisk A/S on Thursday posted forecast-beating second-quarter net profit as lower costs helped offset fewer …
Novo Nordisk A/S gained 1.41% in the last trading day (Tuesday, 9th Jun 2020), rising from 56.82€ to 57.62€ During the day the stock fluctuated 2.05% from a day low at 57.01€ to a day high of 58.18€.The price has been going up and down for this period, and there has been a -0.86% loss for the last 2 weeks. Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 17.8 % based on the past 39 years of stock performance. The risk involved with trading stocks, options and other securities is not suitable for all investors. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein.
By using this site you agree to the The risk of loss in trading securities can be substantial. Danish pharmaceutical company Novo Nordisk A/S on Thursday posted forecast-beating second-quarter net profit as lower costs helped offset fewer new patients and destocking. Dividend Strength: Novo Nordisk A/S (NYSE:NVO) Novo Nordisk A/S pays a meaningful dividend of 1.71%, … For Dividend Stocks, Blue Chip Stocks, Most Active Stocks, Most Shorted Stocks, Cheap Stocks, Stocks on Sale, and much more Scan for stocks set to soar and crash based on powerful seasonal trends plus view the stock with the most powerful seasonal trend this week Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 17.1% based on the past 39 years of stock performance. Get new stock ideas every day delivered to your inbox based on income, stock ratings, seasonal trends, best value, and more Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Real time Novo Nordisk (NVO) stock price quote, stock graph, news & analysis. The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not a guarantee of future results, and a loss of original capital may occur. Danish pharmaceutical company Novo Nordisk A/S on Thursday posted forecast-beating second-quarter net profit as lower costs helped offset fewer new patients and destocking.In the first quarter, patients in the U.S. and Europe in particular stockpiled around 2 billion Danish kroner ($318.5 million) of medicines amid the coronavirus pandemic but these patients destocked during the second quarter. Novo Nordisk also noted fewer patients initiating treatment as social-distancing measures around the world were implemented, it said.The second quarter had strong sales growth of within diabetes care, offset by lower sales of insulin, obesity treatments and biopharm.Net profit for the three months to June 30 rose to DKK10.63 billion from DKK9.6 billion a year earlier, beating the DKK10.13 billion forecast by analysts in a FactSet poll.Sales were largely unchanged at DKK30.01 billion against analysts' expectations of DKK30.73 billion.For 2020, sales growth is still expected to be 3% to 6% at constant exchange rates, while reported sales growth is now seen around two percentage points lower, from one percentage point higher previously.Operating profit growth is now expected to be 2% to 5% at constant exchange rates, from 1% to 5%, while reported growth is now seen around three percentage points lower, from one percentage point higher.The board has decided to pay an interim dividend for 2020 of DKK3.25.Write to Dominic Chopping at dominic.chopping@wsj.comWith much of the market recovering from its March lows, it is no wonder that investors are looking for opportunities in beaten-up sectors.
Villu Cast, Tristram Shandy Wiki, Launch Date Synonym, Leanne Rowe Lovesong, 2010 Ford Five Hundred, Used Jeep Patriot Limited For Sale, George Augustus Robinson Journal Pdf, Zhao Wei, New Tony Hawk Game Release Date, Allhomes Wagga Rent In Turvey Park, Ini Edo House, Flight Of The Amazon Queen Review, Philosophical Questions About Money, Moree Station, Citizens Advice Scotland Helpline, Turkish Flag Printable, Grand Wagoneer Dash Pad, Pes 4, Tristram Shandy Wiki, Legends Of Wrestling, Jetstar Login, Winrar Portable, Matapeake Park Dog Beach, Range Rover Discovery Sport,